Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc.

NNASDAQ:INBS
1.50
USD
-0.26
(-14.77%)
-7.91EPS
6.67MMarket Cap
Feb 18Next Earn

Total Valuation

USD

As of June 30, 2026, Intelligent Bio Solutions Inc. carries a market capitalization of 6.67M, placing it among publicly traded companies globally. Its enterprise value stands at 4.28M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap6.67M
Enterprise Value4.28M

Important Dates

Intelligent Bio Solutions Inc.'s next confirmed earnings release is scheduled for February 18, 2027.

Earnings Date2/18/2027

Share Statistics

As of June 30, 2026, Intelligent Bio Solutions Inc. has 2.91M shares outstanding.

Shares Outstanding2.91M

Valuation Ratios

These figures are as of June 30, 2026. The price-to-sales ratio is 0.86, and the price-to-book ratio stands at 1.21.

PS Ratio0.86
PB Ratio1.21
P/TBV Ratio2.46
P/FCF Ratio-0.30
P/OCF Ratio-0.30

Enterprise Valuation

These figures are as of June 30, 2026. The EV/Sales ratio of 1.01 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 4.28M versus a market cap of 6.67M, with the gap driven by net debt and cash on the balance sheet.

EV / Sales1.01

Financial Position

As of June 30, 2026, Intelligent Bio Solutions Inc. maintains a current ratio of 1.44, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 34.38, indicating elevated leverage, while an interest coverage ratio of -168.32 demonstrates limited ability to service its debt obligations.

Current Ratio1.44
Quick Ratio1.15
Debt / Equity34.38
Debt / EBITDA-0.16
Interest Coverage-168.32

Financial Efficiency

USD

Over the twelve months ended June 30, 2026, Intelligent Bio Solutions Inc. posted a negative return on equity (ROE) of -292.25, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -123.13, reflecting losses generated across the asset base. The company generates approximately 75,608.52 in revenue per employee across its workforce of 55.75, a quick read on workforce productivity versus industry peers. Inventory turnover of 4.11 indicates how many times Intelligent Bio Solutions Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)-292.25
Return on Assets (ROA)-123.13
Revenue Per Employee75,608.52
Employee Count55.75
Inventory Turnover4.11

Stock Price Statistics

USD

As of the close on November 16, 2026, Intelligent Bio Solutions Inc.'s stock has declined approximately 79.18% over the past 52 weeks. The 50-day moving average sits at 1.77, while the 200-day moving average is 2.69.

52-Week Price Change-79.18%
50-Day Moving Average1.77
200-Day Moving Average2.69

Income Statement

USD

Over the twelve months ended June 30, 2026, Intelligent Bio Solutions Inc. generated 4.22M in revenue and converted that into -12.43M in net income, yielding earnings per share of -7.91. EBITDA reached -11.39M, while operating income came in at -12.25M.

Revenue4.22M
Gross Profit2.05M
Operating Income-12.25M
Pretax Income-12.47M
Net Income-12.43M
EBITDA-11.39M
EBIT-12.55M
Earnings Per Share (EPS)-7.91

Balance Sheet

USD

As of June 30, 2026, Intelligent Bio Solutions Inc. holds 3.99M in cash and equivalents against 1.82M in total debt, resulting in a net debt position of -3.99M. Total book value stands at 5.51M, with working capital of 2.17M providing operational flexibility.

Cash & Cash Equivalents3.99M
Total Debt1.82M
Net Debt-3.99M
Equity (Book Value)5.51M
Book Value Per Share1.90
Working Capital2.17M

Cash Flow

USD

Intelligent Bio Solutions Inc. produced -11.93M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -125,731.00 in capital expenditures, free cash flow totaled -12.05M - equivalent to -7.65 per share.

Operating Cash Flow-11.93M
Capital Expenditures-125,731.00
Free Cash Flow-12.05M
FCF Per Share-7.65

Margins

Over the twelve months ended June 30, 2026, Intelligent Bio Solutions Inc. posted a gross margin of 48.63, reflecting its pricing power and cost economics. The operating margin of -290.68 and net profit margin of -294.91 provide insight into operational efficiency.

Gross Margin48.63
Operating Margin-290.68
Pretax Margin-295.80
Profit Margin-294.91
EBITDA Margin-270.15

Dividends & Yields

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -333.15: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -224.70, meaning Intelligent Bio Solutions Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Shareholder Yield-224.70
FCF Yield-333.15

Stock Splits

Intelligent Bio Solutions Inc.'s most recent stock split took place on December 16, 2025 with a 10:1 split ratio.

Last Split Date12/16/2025
Split Ratio10:1

Scores

As of June 30, 2026, Intelligent Bio Solutions Inc. has an Altman Z-Score of -14.55, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-14.55